Financial analysis of cardiovascular wellness program provided to self-insured company from pharmaceutical care provider's perspective

被引:7
作者
Wilson, Justin B. [1 ,2 ]
Osterhaus, Matt C. [3 ,4 ]
Farris, Karen B. [4 ]
Doucette, William R. [4 ]
Currie, Jay D. [4 ]
Bullock, Tammy [3 ,4 ]
Kumbera, Patty [4 ,5 ]
机构
[1] Valumed Pharm, Midwest City, OK USA
[2] Univ Oklahoma, Coll Pharm, Oklahoma City, OK USA
[3] Osterhaus Pharm, Maquoketa, IA USA
[4] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[5] Outcomes Pharmaceut Hlth Care, Des Moines, IA USA
关键词
pharmacoeconomics; community and ambulatory pharmacy; wellness; disease management; pharmacy management;
D O I
10.1331/1544345055001346
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To perform a retrospective financial analysis on the implementation of a self-insured company's wellness program from the pharmaceutical care provider's perspective and conduct sensitivity analyses to estimate costs versus revenues for pharmacies without resident pharmacists, program implementation for a second employer, the second year of the program, and a range of pharmacist wages. Design: Cost-benefit and sensitivity analyses. Setting: Self-insured employer with headquarters in Canton, N.C. Patients: 36 employees at facility in Clinton, Iowa. Interventions: Pharmacist-provided cardiovascular wellness program. Main Outcome Measures: Costs and revenues collected from pharmacy records, including pharmacy purchasing records, billing records, and pharmacists' time estimates. Methods: All costs and revenues were calculated for the development and first year of the intervention program. Costs included initial and follow-up screening supplies, office supplies, screening/ group presentation time, service provision time, documentation/preparation time, travel expenses, claims submission time, and administrative fees. Revenues included initial screening revenues, follow-up screening revenues, group session revenues, and Heart Smart program revenues. Results: For the development and first year of Heart Smart, net benefit to the pharmacy (revenues minus costs) amounted to $2,413. All sensitivity analyses showed a net benefit. For pharmacies without a resident pharmacist, the net benefit was $106; for Heart Smart in a second employer, the net benefit was $6,024; for the second year, the projected net benefit was $6,844; factoring in a lower pharmacist salary, the net benefit was $2,905; and for a higher pharmacist salary, the net benefit was $1,265. Conclusion: For the development and first year of Heart Smart, the revenues of the wellness program in a self-insured company out weighed the costs.
引用
收藏
页码:588 / 592
页数:5
相关论文
共 8 条
[1]  
*AM HEART ASS, 2002, HEART DIS STROK STAT
[2]  
BLUML BM, 2000, J AM PHARM ASSOC, V40, P143
[3]  
Cranor Carole W, 2003, J Am Pharm Assoc (Wash), V43, P173, DOI 10.1331/108658003321480713
[4]   Patient Self-Management Program for Diabetes: First-year clinical, humanistic, and economic outcomes [J].
Garrett, Daniel G. ;
Bluml, Benjamin M. .
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2005, 45 (02) :130-137
[5]   The importance of indirect costs in primary cardiovascular disease prevention - Can we save lives and money with statins? [J].
Grover, SA ;
Ho, V ;
Lavoie, F ;
Coupal, L ;
Zowall, H ;
Pilote, L .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (03) :333-339
[6]   Cost implications of the use of ramipril in high-risk patients based on the Heart Outcomes Prevention Evaluation (HOPE) study [J].
Lamy, A ;
Yusuf, S ;
Pogue, J ;
Gafni, A .
CIRCULATION, 2003, 107 (07) :960-965
[7]  
*NAT CHOL ED PROGR, 2001, PUBL NAT HEART LUNG
[8]  
Norwood G J, 1998, J Am Pharm Assoc (Wash), V38, P755